Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

OBJECTIVES: To compare the 30-day outcome (mortality and/or ICU admission) of patients admitted for moderate-severe SARS-CoV-2 pneumonia treated with dexamethasone after the Recovery study versus those treated with weight-adjusted methylprednisolone. METHODS: Retrospective cohort study of 65 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Aomar-Millán, Ismael F., Fatoul-del Pino, Geoorgette, Torres-Parejo, Úrsula, Pérez Fernández, Laura, Martínez-Diz, Silvia, Salvatierra, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier España, S.L.U. 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870753/
https://www.ncbi.nlm.nih.gov/pubmed/36713976
http://dx.doi.org/10.1016/j.medcle.2023.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870753/
https://www.ncbi.nlm.nih.gov/pubmed/36713976
http://dx.doi.org/10.1016/j.medcle.2023.01.002

Ejemplares similares